145 related articles for article (PubMed ID: 20646367)
21. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
Berglin E; Padyukov L; Sundin U; Hallmans G; Stenlund H; Van Venrooij WJ; Klareskog L; Dahlqvist SR
Arthritis Res Ther; 2004; 6(4):R303-8. PubMed ID: 15225365
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
[TBL] [Abstract][Full Text] [Related]
23. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
24. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
25. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres.
Lappin DF; Apatzidou D; Quirke AM; Oliver-Bell J; Butcher JP; Kinane DF; Riggio MP; Venables P; McInnes IB; Culshaw S
J Clin Periodontol; 2013 Oct; 40(10):907-15. PubMed ID: 23902301
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody for rheumatoid arthritis.
Heidari B; Abedi H; Firouzjahi A; Heidari P
Rheumatol Int; 2010 Sep; 30(11):1465-70. PubMed ID: 19823836
[TBL] [Abstract][Full Text] [Related]
29. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
[TBL] [Abstract][Full Text] [Related]
30. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
31. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
Mikuls TR; Payne JB; Yu F; Thiele GM; Reynolds RJ; Cannon GW; Markt J; McGowan D; Kerr GS; Redman RS; Reimold A; Griffiths G; Beatty M; Gonzalez SM; Bergman DA; Hamilton BC; Erickson AR; Sokolove J; Robinson WH; Walker C; Chandad F; O'Dell JR
Arthritis Rheumatol; 2014 May; 66(5):1090-100. PubMed ID: 24782175
[TBL] [Abstract][Full Text] [Related]
32. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
33. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
[TBL] [Abstract][Full Text] [Related]
34. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
Morita Y; Muro Y; Sugiura K; Tomita Y
Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis].
Araki C; Hayashi N; Moriyama M; Morinobu S; Mukai M; Koshiba M; Kawano S; Kumagai S
Rinsho Byori; 2004 Dec; 52(12):966-72. PubMed ID: 15675342
[TBL] [Abstract][Full Text] [Related]
36. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
Farid SSh; Azizi G; Mirshafiey A
Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
[TBL] [Abstract][Full Text] [Related]
37. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
38. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
[TBL] [Abstract][Full Text] [Related]
39. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
Cho SY; Kang SY; Lee HJ; Lee WI
Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
[TBL] [Abstract][Full Text] [Related]
40. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement.
Bombardieri M; Alessandri C; Labbadia G; Iannuccelli C; Carlucci F; Riccieri V; Paoletti V; Valesini G
Arthritis Res Ther; 2004; 6(2):R137-41. PubMed ID: 15059277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]